Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 28, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Disentangling the myeloma web.

Giovanni Tonon1, Kenneth C Anderson

  • 1Functional Genomics of Cancer Unit, Division of Molecular Oncology, San Raffaele Scientific Institute, Milan, Italy. tonon.giovanni@hsr.it

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|October 13, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proof-of-principle 4-marker spatial profiling reveals distinct, location-independent immune clusters in biliary tract cancers.

Pathology oncology research : POR·2026
Same author

Spatial epitranscriptomics: from Cinderella to queen.

Nature methods·2026
Same author

The histone methyltransferase NSD3 oncogene triggers ribosomal DNA transcription, interfering with FOSL2 in cancer.

Cell death & disease·2026
Same author

DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer.

Cancer research·2026
Same author

The genetic basis of the immune response to SARS-CoV-2 infection and vaccination in the Italian municipality of Vo'.

Frontiers in immunology·2026
Same author

Editorial Expression of Concern: Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers.

Nature medicine·2026
Same journal

Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Clinical Validation of a Multiplex Urine Biomarker Assay for Surveillance of Recurrent Bladder Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Epigenetic Liquid Biopsy Enables Universal Mutation-Agnostic Molecular Surveillance for High-Risk Neuroblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Claudin 18.2 Targeting: A Pan-Cancer Perspective.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancreatic Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same journal

Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
See all related articles

Gene expression profiling in multiple myeloma patients shows prognostic gene signatures. Novel computational tools help integrate diverse data to find reliable predictive markers despite patient heterogeneity.

Area of Science:

  • Genomics
  • Oncology
  • Bioinformatics

Background:

  • Gene expression profiling in multiple myeloma has revealed prognostic gene signatures.
  • Patient heterogeneity currently prevents consensus on the best predictive and prognostic markers.

Purpose of the Study:

  • To identify universal and robust gene expression classifiers for multiple myeloma prognosis.
  • To leverage novel computational tools for integrating heterogeneous patient data.

Main Methods:

  • Utilizing advanced computational tools to analyze gene expression data.
  • Integrating heterogeneous datasets from multiple myeloma patients.

Main Results:

  • Identification of novel computational approaches for analyzing complex genomic data.

More Related Videos

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

Related Experiment Videos

Last Updated: May 28, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

  • Development of strategies to overcome heterogeneity in gene expression profiling.

    • Conclusions:

    • Novel computational tools are crucial for identifying robust prognostic markers in heterogeneous diseases like multiple myeloma.
    • Further research is needed to establish consensus on universal predictive and prognostic signatures.